Forums » Open clinical » Respiratory medicine » ADHD Drugs Show No Apparent Short-Term Risk to Cardiovascular Safety in Kids
|
ADHD Drugs Show No Apparent Short-Term Risk to Cardiovascular Safety in Kids
posted at 20/7/2012 4:19 PM BST
on bmj.com
|
Posts: 645
First: 2/2/2011 Last: 22/5/2013 |
Use of central-nervous-system stimulant drugs in children carries no increased risk for major cardiovascular events in the short term, according to a BMJ study.
Researchers examined 1999–2006 Medicaid data from 28 states on 1.2 million patients between ages 3 and 18 with a new diagnosis of attention-deficit/hyperactivity disorder, adjustment reaction, disturbance of conduct, or emotional disturbance disorder. About a third of patients were prescribed a stimulant drug. The researchers looked for variations in the rate of stroke, acute MI, or sudden cardiac death in users versus nonusers of stimulants.
After a median 2 years' follow-up, there was no apparent difference in the rate of cardiovascular events between users and nonusers.
The authors comment that their study examined stimulant use over the short term, and "the results might not generalize to children who use stimulants over many years |
|
|
Re: ADHD Drugs Show No Apparent Short-Term Risk to Cardiovascular Safety in Kids
posted at 20/7/2012 6:00 PM BST
on bmj.com
|
Posts: 1786
First: 7/3/2009 Last: 22/5/2013 |
The question is what happens with children who have an underlying heart condition such as various valvular findings ( even mild) and various ecg abnormalities (WPW) etc. Looking at a large group of a general population cannot tell us enough about potential risk in those subgroups. Any one who can comment?
|
Forums » Open clinical » Respiratory medicine » ADHD Drugs Show No Apparent Short-Term Risk to Cardiovascular Safety in Kids
